Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

IND cleared in U.S. for phase II study of izokibep in ankylosing spondylitis

Feb. 11, 2021

Engineered cartilage secretes anti-inflammatory drug

Feb. 2, 2021

Merck KGaA patents TLR antagonists

Jan. 28, 2021

First patients dosed in phase II study of GS-248 in systemic sclerosis

Jan. 27, 2021

Rinvoq approved in E.U. for psoriatic arthritis and ankylosing spondylitis

Jan. 26, 2021

Aclaris reports topline phase IIa data on ATI-450 for rheumatoid arthritis

Jan. 20, 2021

Clinical hold for planned phase I/II trial of HST-003 for knee cartilage regeneration

Jan. 20, 2021

Targeting the cartilage EGFR pathway is a promising therapeutic strategy in OA

Jan. 20, 2021

Eli Lilly initiates phase II study of LY-3462817 in rheumatoid arthritis

Jan. 19, 2021

SinoMab initiates phase I trial in China with SN-1011 for autoimmune disease

Jan. 18, 2021

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...